semaglutide fda approval date The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing FDA approves first-ever oral GLP-1RA

The risk of generalised skin reactions, such as widespread rash or urticaria, appears to be low based on current evidence, though trial populations may not fully reflect the diversity of patients who would use the medication in routine clinical practice

"We will continue to focus on the science and defend against this lawsuit vigorously." The suit comes as Novo wages an aggressive battle against Lilly to regain market share in the GLP-1 space, positioning its new obesity pill, strategic price cuts and the new high-dose Wegovy to compete with its rival's top-selling obesity injection Zepbound and diabetes counterpart Mounjaro

This formula provides glutathione exclusively in the reduced GSH form active and ready to work from the moment it is absorbed

We focused on some of the brands we saw regularly advertising on social media